Immunosuppressants protein tyrosine kinase Neuronal Signaling PI3K / Akt / mTOR Metabolism Cell Cycle Epigenetics Cytoskeletal Signaling Angiogenesis DNA damage Proteases Apoptosis Mitogen-activated protein kinase (MAPK) Endocrinology & Hormones GPCR & G Protein Transmembrane Transporters Protein tyrosine kinase /JAK / STAT TGF-beta / Smad Stem Cells & Wnt Nuclear transcription factor (NF-κB) Ubiquitin Microbiology Autophagy
ChemicalBook >   Product Catalog >  Biochemical Engineering >  Inhibitors

Inhibitors

Immunosuppressants protein tyrosine kinase Neuronal Signaling PI3K / Akt / mTOR Metabolism Cell Cycle Epigenetics Cytoskeletal Signaling Angiogenesis DNA damage Proteases Apoptosis Mitogen-activated protein kinase (MAPK) Endocrinology & Hormones GPCR & G Protein Transmembrane Transporters Protein tyrosine kinase /JAK / STAT TGF-beta / Smad Stem Cells & Wnt Nuclear transcription factor (NF-κB) Ubiquitin Microbiology Autophagy
More
Less

Inhibitor refers to substance that can hinder the chemical reactions, biological reactions (including immune response) and biological activity. In present time, commonly used inhibitors include immunosuppressants and inhibitors.

1. Immunosuppressive agents: immunosuppressants system refers to drug that can reduce the immune response. It can selectively suppress certain steps of the immune response and immune cells. Immune response refers to the body’s response to a variety of pathogenic substances. Some reactions are favorable to the body and can enhance the body's resistance to disease; some have adverse effects on the body and can cause tissue damage or disorders of physiological functions (allergy). Therefore, patients suffering from allergic reactions being harmful to the body should be subject to the treatment of immunosuppressant to affect the related immune processes and reduce the immune response of the body.

For the treatment of various autoimmune diseases and weakening the tissue incompatibility, it has been developed of a variety of immunosuppressive agents, some of which have been widely used in clinical practice. Commonly used immunosuppressants include glucocorticoids (prednisone, prednisolone, etc.), alkylating agents (nitric oxide mustard, cyclophosphamide, thiotepa, busulfan, etc.), and antimetabolites (6- mercaptopurine, azathioprine, methotrexate, etc.).

The mechanism of immunosuppressants, though not entirely clear, but is characterized by the following several aspects:
① most kinds of immunosuppressants can simultaneously inhibit cellular and humoral immunity and can be used for organ transplantation and autoimmune disease.
②Its inhibitory effect is strong for the primary immune response while the inhibitory effect against secondary response is weak.
③It can simultaneously act on normal and pathological immunity, therefore, can often lead to some complications.
④These drugs often have strong with serious adverse reactions.

2. Enzyme inhibitors: Enzyme inhibitors refer to compounds or drugs being capable of binding to enzyme and inhibit the enzymatic activity. It is clinically often applied of enzyme inhibitors to specially interfere with certain metabolic system to achieve the therapeutic purposes. For example, people use monoamine oxidase inhibitors as antidepressants; use carbonic anhydrase inhibitors as diuretics; use dopa decarboxylase inhibitors as antihypertensive drugs and use antibiotics such as penicillin, cephalosporins belonging to cell wall synthesis inhibitors. Enzyme inhibitors have applications in veterinary medicine and agriculture. In addition, people can also apply enzyme inhibitors to study the mechanism of the enzyme and metabolic pathways.

Enzyme inhibitors often have similar structure with their natural substrates. For designing the inhibitors according modification of natural substrate, people should first analyze and decide the function of each part of the molecule in binding with enzymes: for binding or not binding or repulsion; secondly, people should know the degree of tolerance of the binding site to the adjacent steric hindrance. Then people can replace each functional group to regulate the strength of interaction with the enzyme.

Inhibitors can be divided into reversible and irreversible, two classes. (1)Inhibitors binding with enzyme through non-covalent bonds are called reversible inhibitor. (2)Inhibitors binding to the enzyme via a covalent bond are irreversible inhibitors with strong binding affinity. They will not be affected by concentration change process such as dialysis or dilution after binding to the enzyme.

Click on the specific product, view the latest prices of the products, information, serving information

Structure:
Chemical Name:
Roxadustat
CAS:
808118-40-3
MF:
C19H16N2O5
Structure:
Chemical Name:
4-[[4-[[4-[(E)-2-cyanoethenyl]-2,6-dimethyl-phenyl]amino]pyrimidin-2-yl]amino]benzonitrile
CAS:
500287-72-9
MF:
C22H18N6
Structure:
Chemical Name:
EST
CAS:
88321-09-9
MF:
C17H30N2O5
Structure:
Chemical Name:
PI-103
CAS:
371935-74-9
MF:
C19H16N4O3
Structure:
Chemical Name:
Andarine
CAS:
401900-40-1
MF:
C19H18F3N3O6
Structure:
Chemical Name:
SIRTINOL
CAS:
410536-97-9
MF:
C26H22N2O2
Structure:
Chemical Name:
Pizotifen Malate
CAS:
5189-11-7
MF:
C23H27NO5S
Structure:
Chemical Name:
Nitenpyram
CAS:
150824-47-8
MF:
C11H15ClN4O2
Structure:
Chemical Name:
5,5'-(2,5-FURANDIYL)BIS-2-THIOPHENEMETHANOL
CAS:
213261-59-7
MF:
C14H12O3S2
Structure:
Chemical Name:
Ifosfamide
CAS:
3778-73-2
MF:
C7H15Cl2N2O2P
Structure:
Chemical Name:
Naloxone hydrochloride dihydrate
CAS:
51481-60-8
MF:
C19H26ClNO6
Structure:
Chemical Name:
Vilazodone Hydrochloride
CAS:
163521-08-2
MF:
C26H28ClN5O2
Structure:
Chemical Name:
MK-2206 2HCl
CAS:
1032350-13-2
MF:
C25H22ClN5O
Structure:
Chemical Name:
(S)-tert-butyl 2-(4-(4-chlorophenyl)-2,3,9-triMethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl)acetate
CAS:
1268524-70-4
MF:
C23H25ClN4O2S
Structure:
Chemical Name:
5-(6-Quinoxalinylmethylene)-2,4-thiazolidinedione
CAS:
648450-29-7
MF:
C12H7N3O2S
Structure:
Chemical Name:
3-[(Aminocarbonyl)amino]-5-(3-fluorophenyl)-N-(3S)-3-piperidinyl-2-Thiophenecarboxamide
CAS:
860352-01-8
MF:
C17H19FN4O2S
Structure:
Chemical Name:
PF-562271
CAS:
717907-75-0
MF:
C21H20F3N7O3S
Structure:
Chemical Name:
Semagacestat
CAS:
425386-60-3
MF:
C19H27N3O4
Structure:
Chemical Name:
Torcetrapib
CAS:
262352-17-0
MF:
C26H25F9N2O4
Structure:
Chemical Name:
Rupatadine Fumarate
CAS:
182349-12-8
MF:
C26H26ClN3.C4H4O4
Structure:
Chemical Name:
10,11-Dihydro-alpha-methyl-10-oxo-dibenzo[b,f]thiepin-2-acetic acid
CAS:
74711-43-6
MF:
C17H14O3S
Structure:
Chemical Name:
KU-0063794
CAS:
938440-64-3
MF:
C25H31N5O4
Structure:
Chemical Name:
N-[3-[[5-Iodo-4-[[3-[(2-thienylcarbonyl)amino]propyl]amino]-2-pyrimidinyl]amino]phenyl]-1-pyrrolidinecarboxamide
CAS:
702675-74-9
MF:
C23H26IN7O2S
Structure:
Chemical Name:
N-(2-Aminophenyl)-4-([[4-(pyridin-3-yl)pyrimidin-2-yl]amino]methyl)benzamide
CAS:
726169-73-9
MF:
C23H20N6O
Structure:
Chemical Name:
GW788388
CAS:
452342-67-5
MF:
C25H23N5O2
Structure:
Chemical Name:
LY2109761
CAS:
700874-71-1
MF:
C26H27N5O2
Structure:
Chemical Name:
Naratriptan Hydrochloride
CAS:
143388-64-1
MF:
C17H25N3O2S.ClH
Structure:
Chemical Name:
T0070907
CAS:
313516-66-4
MF:
C12H8ClN3O3
Structure:
Chemical Name:
Cilomilast
CAS:
153259-65-5
MF:
C20H25NO4
Structure:
Chemical Name:
SNS-032
CAS:
345627-80-7
MF:
C17H24N4O2S2
Structure:
Chemical Name:
Cyclosporin A
CAS:
59865-13-3
MF:
C62H111N11O12
Structure:
Chemical Name:
WZ4002
CAS:
1213269-23-8
MF:
C25H27ClN6O3
Structure:
Chemical Name:
N-(5-tert-Butylisoxazol-3-yl)-N'-{4-[7-(2-morpholin-4-ylethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea
CAS:
950769-58-1
MF:
C29H32N6O4S
Structure:
Chemical Name:
Daclatasvir
CAS:
1009119-64-5
MF:
C40H50N8O6
Structure:
Chemical Name:
Infigratinib
CAS:
872511-34-7
MF:
C26H31Cl2N7O3
Structure:
Chemical Name:
Ledipasvir
CAS:
1256388-51-8
MF:
C49H54F2N8O6
Structure:
Chemical Name:
JTT-705
CAS:
211513-37-0
MF:
C23H35NO2S
Structure:
Chemical Name:
Cyclophosphamide monohydrate
CAS:
6055-19-2
MF:
C7H17Cl2N2O3P
Structure:
Chemical Name:
ENALAPRILAT DIHYDRATE
CAS:
84680-54-6
MF:
C18H26N2O6
Structure:
Chemical Name:
Eflone
CAS:
3801-06-7
MF:
C24H31FO5
Structure:
Chemical Name:
Fenazox
CAS:
61618-27-7
MF:
C15H16NNaO4
Structure:
Chemical Name:
Panobinostat
CAS:
404950-80-7
MF:
C21H23N3O2
Structure:
Chemical Name:
AZD 5438
CAS:
602306-29-6
MF:
C18H21N5O2S
Structure:
Chemical Name:
6-CHLORO-2,3,4,9-TETRAHYDRO-1H-CARBAZOLE-1-CARBOXAMIDE
CAS:
49843-98-3
MF:
C13H13ClN2O
Structure:
Chemical Name:
Linsitinib
CAS:
867160-71-2
MF:
C26H23N5O
Structure:
Chemical Name:
MLN-8237
CAS:
1028486-01-2
MF:
C27H20ClFN4O4
Structure:
Chemical Name:
Alectinib
CAS:
1256580-46-7
MF:
C30H34N4O2
Structure:
Chemical Name:
GSK1349572
CAS:
1051375-16-6
MF:
C20H19F2N3O5
Structure:
Chemical Name:
Suvorexant
CAS:
1030377-33-3
MF:
C23H23ClN6O2
Structure:
Chemical Name:
ZM 336372
CAS:
208260-29-1
MF:
C23H23N3O3
Structure:
Chemical Name:
2-Cyano-3-hydroxy-N-(4'-trifluoromethylphenyl)-crotone amide
CAS:
108605-62-5
MF:
C12H9F3N2O2
Structure:
Chemical Name:
MOEXIPRIL HYDROCHLORIDE
CAS:
82586-52-5
MF:
C27H35ClN2O7
Structure:
Chemical Name:
Necrostatin-1
CAS:
4311-88-0
MF:
C13H13N3OS
Structure:
Chemical Name:
Tariquidar
CAS:
206873-63-4
MF:
C38H38N4O6
Structure:
Chemical Name:
Ataluren
CAS:
775304-57-9
MF:
C15H9FN2O3
Structure:
Chemical Name:
NVP-TAE684
CAS:
761439-42-3
MF:
C30H40ClN7O3S
Structure:
Chemical Name:
Elvitegravir
CAS:
697761-98-1
MF:
C23H23ClFNO5
Structure:
Chemical Name:
Amuvatinib
CAS:
850879-09-3
MF:
C23H21N5O3S
Structure:
Chemical Name:
Foretinib (GSK1363089)
CAS:
849217-64-7
MF:
C34H34F2N4O6
Structure:
Chemical Name:
R-406
CAS:
841290-80-0
MF:
C22H23FN6O5
Structure:
Chemical Name:
XL147
CAS:
956958-53-5
MF:
C21H16N6O2S2
Structure:
Chemical Name:
Ostarine
CAS:
841205-47-8
MF:
C19H14F3N3O3
Structure:
Chemical Name:
LY 2157299
CAS:
700874-72-2
MF:
C22H19N5O
Structure:
Chemical Name:
(R)-Baclofen
CAS:
69308-37-8
MF:
C10H12ClNO2
Structure:
Chemical Name:
ZSTK474
CAS:
475110-96-4
MF:
C19H21F2N7O2
Structure:
Chemical Name:
PLERIXAFOR
CAS:
110078-46-1
MF:
C28H54N8
Structure:
Chemical Name:
8-[(E)-2-(3,4-dimethoxyphenyl)ethenyl]-1,3-diethyl-7-methyl-purine-2,6 -dione
CAS:
155270-99-8
MF:
C20H24N4O4
Structure:
Chemical Name:
Dovitinib
CAS:
405169-16-6
MF:
C21H21FN6O
Structure:
Chemical Name:
Fedratinib
CAS:
936091-26-8
MF:
C27H36N6O3S
Structure:
Chemical Name:
2-[(6-Amino-9H-purin-9-yl)methyl]-5-methyl-3-(2-methylphenyl)-4(3H)-quinazolinone
CAS:
371242-69-2
MF:
C22H19N7O
Structure:
Chemical Name:
Omarigliptin (MK-3102)
CAS:
1226781-44-7
MF:
C17H20F2N4O3S
Structure:
Chemical Name:
PD184352
CAS:
212631-79-3
MF:
C17H14ClF2IN2O2
Structure:
Chemical Name:
LUMIRACOXIB
CAS:
220991-20-8
MF:
C15H13ClFNO2
Structure:
Chemical Name:
Obatoclax mesilate
CAS:
803712-79-0
MF:
C20H19N3O.CH4O3S
Structure:
Chemical Name:
GF109203X
CAS:
133052-90-1
MF:
C25H24N4O2
Structure:
Chemical Name:
Prucalopride
CAS:
179474-81-8
MF:
C18H26ClN3O3
Structure:
Chemical Name:
HA14-1
CAS:
65673-63-4
MF:
C17H17BrN2O5
Structure:
Chemical Name:
ABT 263
CAS:
923564-51-6
MF:
C47H55ClF3N5O6S3
Structure:
Chemical Name:
Mirabegron
CAS:
223673-61-8
MF:
C21H24N4O2S
Structure:
Chemical Name:
Momelotinib
CAS:
1056634-68-4
MF:
C23H22N6O2
Structure:
Chemical Name:
Bardoxolone methyl
CAS:
218600-53-4
MF:
C32H43NO4
Structure:
Chemical Name:
Afatinib dimaleate
CAS:
850140-73-7
MF:
C28H29ClFN5O7
Structure:
Chemical Name:
CO-1686
CAS:
1374640-70-6
MF:
C27H28F3N7O3
Structure:
Chemical Name:
ALMOTRIPTAN
CAS:
181183-52-8
MF:
C21H31N3O7S
Structure:
Chemical Name:
VARESPLADIB
CAS:
172732-68-2
MF:
C21H20N2O5
Structure:
Chemical Name:
Orantinib (SU6668)
CAS:
252916-29-3
MF:
C18H18N2O3
Structure:
Chemical Name:
BI 2536
CAS:
755038-02-9
MF:
C28H39N7O3
Structure:
Chemical Name:
BUCLIZINE, DIHYDROCHLORIDE
CAS:
129-74-8
MF:
C28H35Cl3N2
Structure:
Chemical Name:
lubiprostone
CAS:
333963-40-9
MF:
C20H32F2O5
Structure:
Chemical Name:
Lumacaftor (VX-809)
CAS:
936727-05-8
MF:
C24H18F2N2O5
Structure:
Chemical Name:
SRT1720
CAS:
1001645-58-4
MF:
C25H24ClN7OS
Structure:
Chemical Name:
Azilsartan Medoxomil
CAS:
863031-21-4
MF:
C30H24N4O8
Structure:
Chemical Name:
(S)-1-[4-[[2-(2-Aminopyrimidin-5-yl)-7-methyl-4-(morpholin-4-yl)thieno[3,2-d]pyrimidin-6-yl]methyl]piperazin-1-yl]-2-hydroxypropan-1-one
CAS:
1032754-93-0
MF:
C23H30N8O3S
Structure:
Chemical Name:
Dabrafenib
CAS:
1195765-45-7
MF:
C23H20F3N5O2S2
Structure:
Chemical Name:
Belinostat (PXD101)
CAS:
414864-00-9
MF:
C15H14N2O4S
Structure:
Chemical Name:
API-2
CAS:
35943-35-2
MF:
C13H16N6O4
Structure:
Chemical Name:
(R)-Tomoxetine
CAS:
83015-26-3
MF:
C17H21NO
Structure:
Chemical Name:
GW9662
CAS:
22978-25-2
MF:
C13H9ClN2O3
Structure:
Chemical Name:
SU 11274
CAS:
658084-23-2
MF:
C28H30ClN5O4S
Structure:
Chemical Name:
TRAM-34
CAS:
289905-88-0
MF:
C22H17ClN2